Lung cancer therapy response calls for new thinking

May 15, 2008 Lung cancer therapy response calls for new thinking Shalmali Pal -------------------------------------------------------------------------------- CT multitasks in the lungs, serving as a tool for cancer screening, disease diagnosis, lesion characterization, and lung cancer treatment response. In a talk at the 2008 Stanford International Symposium on Multidetector-Row CT in Las Vegas, Michael McNitt-Gray, Ph.D., posited that CT can be used more effectively to assess treatment response in lung cancer patients, but clinicians must look beyond current response parameters. The Response Evaluation Criteria in Solid Tumors (RECIST) is the standard for treatment evaluation, said McNitt-Gray, director of the Biomedical Physics Graduate Program at the Thoracic Imaging Research Group, based at the University of California, Los Angeles.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC